3 Emerging Market Stars Set To Explode: Vodafone Group plc, PZ Cussons plc & Hutchison China Meditech Limited

Royston Wild explains why Vodafone Group plc (LON: VOD), PZ Cussons plc (LON PZC) and Hutchison China Meditech Limited (LON: HCM) are stunning long-term stock picks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am championing three top-tier emerging market players.

Ring up a fortune

Much has been made of Vodafone’s (LSE: VOD) performance improvement in Europe, and with good reason — the company sources two-thirds of total revenues from this region. But investors should not overlook the increasing contribution the firm’s Africa, Middle East and Asia Pacific (or AMAP) territory is making.

Indeed, Vodafone saw organic service revenues in this marketplace surge 6.4% between April and September, and customer numbers swelled by 8.9 million to more than 330 million. In particular, Vodafone’s Project Spring investment scheme has worked wonders in addressing ‘rapid’ data demand growth in these regions — the number of 3G customers in India surged 75% in the first half, to 23.8 million, and Vodafone plans to roll out 4G in the country in the next few months.

As well as boosting its position in the core telecoms arena, Vodafone is also spreading its wings in the mobile money sector. The company announced today it was expanding its hugely-successful, Africa-focussed M-Pesa service into Ghana. This division saw transactions leap 26% in April-September, to more than 2 billion.

Vodafone clearly sees emerging markets as a key lever for future earnings growth. With the Newbury firm aggressively modernising and expanding its operations, I fully expect sales to head higher along with stampeding consumer spending power in these ‘new’ regions.

Scrubbing up a treat

I believe household goods giant PZ Cussons’ (LSE: PZC) focus on Asia, Africa and Australasia also makes it a terrific long-term stock selection. The problem of adverse exchange rates is likely to remain a problem for some time longer, but the company can rely on its stable of market-leading products — from Imperial Leather soap and shower gels to five:AM organic foods — to keep revenues edging higher.

Indeed, the exceptional pricing power of such labels is allowing the firm to traverse economic cooling in its far-flung territories, and a steady trend of product roll-outs should keep the top-line chugging higher.

Medical marvel

Healthcare play Hutchison China Meditech (LSE: HCM), or ‘Chi-Med’ as it is better known, has grand ambitions to become the largest drugs manufacturer in the white-hot Chinese marketplace, making it worthy of more than a cursory glance from growth hunters in my opinion.

With patent protection having been secured for its sales-driving SXBXP cardiovascular drug up until 2029, Chi-Med is now hunkering down on bringing its bubbly product pipeline to fruition.

The Cayman Islands business announced last month that Phase I testing had commenced on its sulfatinib oncology drug in the US. And this followed news that its HMPL‑523 therapy — used to treat spleen tyrosine kinase — was about to enter Phase II trials.

As healthcare investment ratchets higher across China and South-East Asia, I reckon Chi-Med could be set to enjoy smashing revenues growth in the years ahead.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK owns shares of PZ Cussons. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

The Standard Chartered share price leaps on FY dividend and buyback news. Time to buy?

An 8% jump for a UK-listed bank on 2023 results? That's what just happened to the Standard Chartered share price.…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Can Lloyds shares get any cheaper?

Lloyds shares have fallen further following the release of the bank's 2023 results. This Fool senses now is a time…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

£7,000 of money to spare? Here’s how I’d aim to turn that into £1,000 in annual extra income

Christopher Ruane explains how he would aim to generate a four figure income to cushion his future, all with dividend…

Read more »

British union jack flag and Parliament house at city of Westminster in the background
Investing Articles

Is this stellar dividend growth stock the only no-brainer buy on the entire FTSE 100?

Picking shares requires careful thought and analysis, but this FTSE 100 growth stock appears to be pressing all the right…

Read more »

Investing Articles

I bought 422 Glencore shares in July and 232 in September. Here’s what they’re worth now

Glencore shares have had a rough ride leaving Harvey Jones out of pocket. Should he cut his losses or average…

Read more »

Man smiling and working on laptop
Investing Articles

Here’s why I’m investing most of my savings in FTSE 100 shares!

I think investing in FTSE 100 shares is one of the best ways that UK investors can make long-term returns.…

Read more »

Newspaper and direction sign with investment options
Investing Articles

When cheap markets meet favourable conditions, sentiment flips very quickly

London’s stock market is cheap — some sectors, even cheaper. Given a change in sentiment, the uprating could be substantial.

Read more »

Investing Articles

Empty Stocks and Shares ISA? I’d snap up these 3 stocks to start with!

Sumayya Mansoor explains how she would start to build wealth from scratch with an empty Stocks and Shares ISA and…

Read more »